Skip to results
Modify your search
NARROW
1-8 of 8
Authors: Inna Smalley
Journal Article
EDITOR'S CHOICE
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions Open Access
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1781–1804, https://doi.org/10.1093/neuonc/noae103
Published: 21 June 2024
Journal Article
CTIM-01. TITLE: PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD): PRELIMINARY RESULTS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii59, https://doi.org/10.1093/neuonc/noac209.233
Published: 14 November 2022
Journal Article
NCMP-04. COMBINATION BRAF/MEK INHIBITION IMPROVES SURVIVAL WITH LEPTOMENINGEAL DISEASE FROM MELANOMA IN A SINGLE INSTITUTIONAL REVIEW AT MOFFITT CANCER CENTER Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii191, https://doi.org/10.1093/neuonc/noac209.732
Published: 14 November 2022
Journal Article
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma Open Access
Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1673–1686, https://doi.org/10.1093/neuonc/noac054
Published: 25 February 2022
Journal Article
BIOM-02. LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi10, https://doi.org/10.1093/neuonc/noab196.034
Published: 12 November 2021
Journal Article
TMOD-02. IN VITRO & IN VIVO CULTURE OF PATIENT DERIVED (PD) CSF-CTCS IN LEPTOMENINGEAL DISEASE (LMD) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii227–ii228, https://doi.org/10.1093/neuonc/noaa215.953
Published: 09 November 2020
Journal Article
CMET-26. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCS IN LEPTOMENINGEAL DISEASE (LMDZ) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi57, https://doi.org/10.1093/neuonc/noz175.227
Published: 11 November 2019
Journal Article
EXTH-39. DETECTION, MOLECULAR PROFILING AND CULTURE OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) IN MELANOMA TO IMPROVE DIAGNOSIS AND TREATMENT STRATEGIES Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi93, https://doi.org/10.1093/neuonc/noy148.387
Published: 05 November 2018
